The effect of phosphorylated ribavirin on a vesicular stomatitis virus (VSV) in vitro tanscription reaction was examined. Viral mRNA synthesized in the presence of the 5' mono-, di-, and triphosphorylated forms of the drug translated with equal efficiencies under the test conditions. However, all three phosphorylated species inhibited VSV transcription. The mono-and diphosphorylated forms of the drug possessed approximately two to three times the inhibitory activity as the triphosphorylated form. Transcripts synthesized in the presence of drug were full length and were absent of incorporated drug. Inhibition by ribavirin 5'-diphosphate could be reversed by the addition of UTP, CTP, and GTP, while the addition of GDP to the reaction did not reverse inhibition. Ribavirin diphosphate was added to a La Crosse virus in vitro transcription assay to determine whether an inhibitory effect could be established in a viral system that was more sensitive to ribavirin than was VSV; it led to profound inhibition of RNA synthesis at concentrations as low as 0.1 ,ug/ml. These data suggest that ribavirin has an effect on the initial steps of transcription by some RNA-dependent RNA polymerases and that this effect may be mediated by several phosphorylated forms.Ribavirin (1-0-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) is a broad-spectrum antiviral agent whose molecular mode of action remains controversial. The drug was approved by the Food and Drug Administration in 1986 for aerosol use in infants with serious infection due to respiratory syncytial virus. Ribavirin is currently under clinical investigation against a variety of other viral illnesses, including those due to influenza virus and human immunodeficiency virus. However, the drug possesses in vitro activity against a remarkably broad spectrum of viral pathogens, including both DNA and RNA viruses (11), suggesting that its full clinical potential has yet to be realized.Several theories regarding the molecular mode of action of ribavirin have been proposed. One hypothesis states that the drug leads to decreased intracellular pools of GTP, indirectly suppressing viral nucleic acid synthesis (9, 15). A more recent hypothesis proposes that ribavirin therapy of viralinfected cells results in the synthesis of RNA with abnormal or absent 5' cap structures, which in turn leads to inefficient translation of viral transcripts (6). A third hypothesis states that the drug has a direct suppressive effect on viral polymerase activity; however, such activity has been demonstrated only for influenza virus (4,17,18). None of these hypotheses are mutually exclusive, and indeed, they may indicate that ribavirin acts in a complex, multiple-site fashion. In previous experiments (16) in which the effect of ribavirin on vesicular stomatitis virus (VSV) grown in Chinese hamster ovary cells was examined, it was indicated that the drug leads to the synthesis of inefficiently translated viral mRNA, with little demonstrable effect on viral polymerase, lending support to the hypothesis that the dr...